RSS

infectious disease

Spotting the signs and symptoms of various infectious diseases can mean the difference between life and death. According to research in the journal Epidemiology and Infection, public awareness campaigns are vital in stopping infections spreading more

Analysis

Monoclonal antibodies (MAb) solutions are a major class of biopharmaceuticals with various applications. They are important for treating diseases such as cancer, inflammation, allergies, infectious diseases and cardiovascular diseases. more

Visterra and Vir Biotechnology have entered into a research collaboration, exclusive licence and option agreement for the development and commercialisation of select programmes for infectious diseases. more

News

New research shows that the common allergy drug loratadine (Claritin) could be effective in treating lyme disease more

News

Catalent has signed an exclusive licencing agreement to access Excelimmune's antibody combination therapy technology platform, which has the potential to pave the way for more consistent, cost-effective production of antibody combinations. more

News

Nabriva Therapeutics, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, has appointed Elyse Seltzer, MD, as chief medical officer. more

News

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) announced breaking developments in the global fight against infections... more

News

The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (April 24th, 2015). more

News

Carbapenem resistance consortium includes AstraZeneca, Cepheid, Cubist, and GSK more